164 results
Page 5 of 9
6-K
EX-99.2
tpk 8vm3t965vdgtmd
27 Nov 19
Condensed Consolidated Interim Financial Statements
5:09pm
6-K
EX-99.1
bpisgbvuc8kaks3w
26 Nov 19
RepliCel Provides 2019 Year-End Update
12:41pm
6-K
EX-99.5
klhfb39l1txau53
6 Nov 19
Notice of Annual General and Special Meeting of Shareholders
12:00am
6-K
EX-99.1
5or kps1jixosi
24 Sep 19
Current report (foreign)
1:49pm
6-K
EX-99.2
h77a83ig2wucm tyd
20 Sep 19
51-102F3 Material Change Report
1:31pm
6-K
EX-99.2
qagpkbwge
11 Sep 19
51-102F3 Material Change Report
12:13pm
6-K
EX-99.3
cc1a9aox1f0x yyk
11 Sep 19
51-102F3 Material Change Report
12:13pm
6-K
EX-99.1
706507b8 88000wlz09
10 Sep 19
RepliCel's Partner, YOFOTO (China) Health, Unveils its Inaugural Cell Therapy Manufacturing Facility in China
11:22am
6-K
EX-99.1
szntjeh1667y6jb9gg
29 Aug 19
RepliCel Life Sciences Retains Dermatology Sales and Marketing Executive to Guide the Global Commercial Strategy for its Automated Dermal Injector
11:47am
6-K
EX-99.2
5wiursczi
23 Aug 19
Condensed Consolidated Interim Financial Statements
3:47pm
6-K
EX-99.2
vn64elmnq7 zd3q
30 May 19
Condensed Consolidated Interim Financial Statements
4:20pm
6-K
EX-99.1
qn2s7p
16 Apr 19
RepliCel Secures Several New Patents for its Regenerative Medicine Technologies
10:59am
6-K
EX-99.1
7w6yds5v55pexah5mp
26 Mar 19
Current report (foreign)
1:45pm
6-K
EX-99.1
5jimhfsqrgnjj
19 Mar 19
RepliCel Reignites its First-in-Japan Strategy
12:11pm
6-K
EX-99.1
kzxk l5qmabi742w2nwc
6 Mar 19
51-102F3 Material Change Report
4:53pm
6-K
EX-99.1
okifsvnk7 1guwe
5 Mar 19
RepliCel CEO Provides 2019 Shareholder Update
10:41am
6-K
EX-99.1
xilx6
23 Jan 19
51-102F3 Material Change Report
12:44pm
6-K
EX-99.2
725vla67
26 Nov 18
Current report (foreign)
4:20pm
6-K
EX-99.1
hsfsas1
6 Nov 18
RepliCel Life Sciences Appoints Head of Clinical and Regulatory Affairs
11:03am